BRIEF—New alliance to boost medical cannabis access in Canada

The Canadian branch of Novartis’ generics business, Sandoz, has formed an alliance with Novar Canada and Tilray to boost access to medical cannabis products.

Eight Sandoz and Tilray co-branded oil and capsule medical cannabis products are currently available to 270,000 Canadian patients.

The new alliance has been formed to “conduct research into product innovation and dosing, and enhance healthcare professionals and patient education” in this area.